Prevention of acute kidney injury using vasoactive or antiplatelet treatment: Three strikes and out?

JAMA - Journal of the American Medical Association

Volumn 312, Issue 21, 2014, Pages 2221-2222

  Winkelmayer, Wolfgang C ^a   Finkel, Kevin W ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLONIDINE; DOPAMINE; FENOLDOPAM; PLACEBO; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTITHROMBOCYTIC AGENT; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HEART SURGERY; HUMAN; HYPOTENSION; INCIDENCE; INJURY SEVERITY; KIDNEY BLOOD FLOW; LOW DRUG DOSE; MORTALITY; MULTICENTER STUDY (TOPIC); NONHUMAN; PRACTICE GUIDELINE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL PROTECTION; RISK ASSESSMENT; SECONDARY PREVENTION; ACUTE KIDNEY INJURY; FEMALE; MALE; PROCEDURES; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ASPIRIN; CARDIAC SURGICAL PROCEDURES; CLONIDINE; FEMALE; FENOLDOPAM; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; RENAL REPLACEMENT THERAPY; VASODILATOR AGENTS;

EID: 84914678219     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.14548     Document Type: Editorial

References (12)

1. Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY. Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol. 2013;24(1):37-42.
2. Lenihan CR, Montez-Rath ME, Mora Mangano CT, Chertow GM, Winkelmayer WC. Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg. 2013;95(1):20-28.
3. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365-3370.
4. Garg AX, Devereaux PJ, Yusuf S, et al; CORONARY Investigators. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. JAMA. 2014;311(21):2191-2198.
5. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(2). http://www.kdigo.org/clinical-practice-guidelines/pdf/KDIGO%20AKI%20Guideline.pdf. March 2012.
6. Garg AX, Kurz A, Sessler DI, et al; POISE-2 Investigators. Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. JAMA. doi:10.1001/jama.2014.15284.
7. Bove T, Zangrillo A, Guarracino F, et al. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial [published online September 29, 2014]. JAMA. doi:10.1001/jama.2014.13573.
8. Marik PE, Iglesias J; NORASEPT II Study Investigators. Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. Am J Med. 1999;107(4):387-390.
9. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med. 2005;142(7):510-524.
10. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J; Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet. 2000;356(9248):2139-2143.
11. Lauschke A, Teichgräber UK, Frei U, Eckardt KU. 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 2006;69(9):1669-1674.
12. Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol. 2004;15(2):411-419.